nodes	percent_of_prediction	percent_of_DWPC	metapath
Guanabenz—Guanfacine—hypertension	0.276	1	CrCtD
Guanabenz—Adrenergic alpha2-Agonists—Guanfacine—hypertension	0.188	0.569	CiPCiCtD
Guanabenz—Adrenergic alpha2-Agonists—Clonidine—hypertension	0.142	0.431	CiPCiCtD
Guanabenz—NISCH—hypertension	0.0948	0.598	CbGaD
Guanabenz—ADRA2B—hypertension	0.0442	0.279	CbGaD
Guanabenz—NISCH—Guanfacine—hypertension	0.0388	0.253	CbGbCtD
Guanabenz—ADRA2A—hypertension	0.0194	0.122	CbGaD
Guanabenz—NISCH—Clonidine—hypertension	0.019	0.124	CbGbCtD
Guanabenz—ADRA2B—Guanfacine—hypertension	0.00847	0.0552	CbGbCtD
Guanabenz—ADRA2C—Fenoldopam—hypertension	0.00759	0.0495	CbGbCtD
Guanabenz—ADRA2B—Fenoldopam—hypertension	0.0072	0.0469	CbGbCtD
Guanabenz—ADRA2A—Methyldopa—hypertension	0.00692	0.0452	CbGbCtD
Guanabenz—ADRA2A—Guanfacine—hypertension	0.00589	0.0384	CbGbCtD
Guanabenz—ADRA2B—Prazosin—hypertension	0.00546	0.0356	CbGbCtD
Guanabenz—ADRA2A—Fenoldopam—hypertension	0.00501	0.0326	CbGbCtD
Guanabenz—ADRA2C—Carvedilol—hypertension	0.00496	0.0324	CbGbCtD
Guanabenz—ADRA2B—Carvedilol—hypertension	0.00471	0.0307	CbGbCtD
Guanabenz—ADRA2A—Doxazosin—hypertension	0.00462	0.0301	CbGbCtD
Guanabenz—ADRA2C—Clonidine—hypertension	0.00436	0.0284	CbGbCtD
Guanabenz—ADRA2B—Clonidine—hypertension	0.00413	0.027	CbGbCtD
Guanabenz—ADRA2A—Prazosin—hypertension	0.00379	0.0247	CbGbCtD
Guanabenz—ADRA2A—Carvedilol—hypertension	0.00328	0.0214	CbGbCtD
Guanabenz—ADRA2A—Clonidine—hypertension	0.00288	0.0188	CbGbCtD
Guanabenz—CYP1A2—Triamterene—hypertension	0.00256	0.0167	CbGbCtD
Guanabenz—CYP1A2—Betaxolol—hypertension	0.00212	0.0138	CbGbCtD
Guanabenz—CYP1A2—Nisoldipine—hypertension	0.00186	0.0122	CbGbCtD
Guanabenz—CYP1A2—Irbesartan—hypertension	0.00147	0.00957	CbGbCtD
Guanabenz—CYP1A2—Amlodipine—hypertension	0.00144	0.00939	CbGbCtD
Guanabenz—CYP1A2—Nifedipine—hypertension	0.00134	0.00876	CbGbCtD
Guanabenz—CYP1A2—Carvedilol—hypertension	0.00132	0.00862	CbGbCtD
Guanabenz—CYP1A2—Propranolol—hypertension	0.00122	0.00793	CbGbCtD
Guanabenz—CYP1A2—Clonidine—hypertension	0.00116	0.00757	CbGbCtD
Guanabenz—CYP1A2—Losartan—hypertension	0.000946	0.00617	CbGbCtD
Guanabenz—CYP1A2—Verapamil—hypertension	0.000835	0.00545	CbGbCtD
Guanabenz—Guanfacine—NISCH—hypertension	0.000746	0.598	CrCbGaD
Guanabenz—Guanfacine—ADRA2B—hypertension	0.000348	0.279	CrCbGaD
Guanabenz—CYP1A2—urine—hypertension	0.000281	0.0836	CbGeAlD
Guanabenz—NISCH—myocardium—hypertension	0.00026	0.0774	CbGeAlD
Guanabenz—NISCH—nephron tubule—hypertension	0.000191	0.0567	CbGeAlD
Guanabenz—NISCH—adrenal cortex—hypertension	0.000188	0.0558	CbGeAlD
Guanabenz—NISCH—heart—hypertension	0.000181	0.054	CbGeAlD
Guanabenz—NISCH—smooth muscle tissue—hypertension	0.00018	0.0536	CbGeAlD
Guanabenz—NISCH—decidua—hypertension	0.000176	0.0525	CbGeAlD
Guanabenz—NISCH—cortex of kidney—hypertension	0.000163	0.0486	CbGeAlD
Guanabenz—Guanfacine—ADRA2A—hypertension	0.000153	0.122	CrCbGaD
Guanabenz—NISCH—medulla oblongata—hypertension	0.000146	0.0435	CbGeAlD
Guanabenz—NISCH—adrenal gland—hypertension	0.000135	0.0403	CbGeAlD
Guanabenz—ADRA2C—cardiac ventricle—hypertension	0.000126	0.0376	CbGeAlD
Guanabenz—ADRA2C—myocardium—hypertension	0.000119	0.0353	CbGeAlD
Guanabenz—ADRA2C—nephron tubule—hypertension	8.7e-05	0.0259	CbGeAlD
Guanabenz—ADRA2C—adrenal cortex—hypertension	8.56e-05	0.0255	CbGeAlD
Guanabenz—ADRA2C—heart—hypertension	8.28e-05	0.0247	CbGeAlD
Guanabenz—ADRA2C—decidua—hypertension	8.06e-05	0.024	CbGeAlD
Guanabenz—ADRA2C—kidney—hypertension	7.65e-05	0.0228	CbGeAlD
Guanabenz—ADRA2C—cortex of kidney—hypertension	7.45e-05	0.0222	CbGeAlD
Guanabenz—ADRA2C—cardiac atrium—hypertension	7.08e-05	0.0211	CbGeAlD
Guanabenz—ADRA2C—medulla oblongata—hypertension	6.68e-05	0.0199	CbGeAlD
Guanabenz—ADRA2A—heart—hypertension	6.61e-05	0.0197	CbGeAlD
Guanabenz—ADRA2A—decidua—hypertension	6.43e-05	0.0191	CbGeAlD
Guanabenz—ADRA2C—adrenal gland—hypertension	6.18e-05	0.0184	CbGeAlD
Guanabenz—ADRA2A—cortex of kidney—hypertension	5.94e-05	0.0177	CbGeAlD
Guanabenz—ADRA2A—cardiac atrium—hypertension	5.65e-05	0.0168	CbGeAlD
Guanabenz—ADRA2A—medulla oblongata—hypertension	5.33e-05	0.0159	CbGeAlD
Guanabenz—ADRA2A—adrenal gland—hypertension	4.93e-05	0.0147	CbGeAlD
Guanabenz—ADRA2C—central nervous system—hypertension	4.83e-05	0.0144	CbGeAlD
Guanabenz—CYP1A2—endocrine gland—hypertension	4.65e-05	0.0139	CbGeAlD
Guanabenz—ADRA2A—endocrine gland—hypertension	4.28e-05	0.0127	CbGeAlD
Guanabenz—ADRA2A—central nervous system—hypertension	3.85e-05	0.0115	CbGeAlD
Guanabenz—Hypersensitivity—Enalapril—hypertension	6.55e-06	0.000122	CcSEcCtD
Guanabenz—Abdominal pain—Perindopril—hypertension	6.55e-06	0.000122	CcSEcCtD
Guanabenz—Body temperature increased—Perindopril—hypertension	6.55e-06	0.000122	CcSEcCtD
Guanabenz—Diarrhoea—Olmesartan—hypertension	6.54e-06	0.000122	CcSEcCtD
Guanabenz—Headache—Eplerenone—hypertension	6.54e-06	0.000122	CcSEcCtD
Guanabenz—Rash—Nifedipine—hypertension	6.53e-06	0.000122	CcSEcCtD
Guanabenz—Nervous system disorder—Ramipril—hypertension	6.53e-06	0.000122	CcSEcCtD
Guanabenz—Dermatitis—Nifedipine—hypertension	6.53e-06	0.000122	CcSEcCtD
Guanabenz—Abdominal pain—Irbesartan—hypertension	6.52e-06	0.000122	CcSEcCtD
Guanabenz—Body temperature increased—Irbesartan—hypertension	6.52e-06	0.000122	CcSEcCtD
Guanabenz—Thrombocytopenia—Ramipril—hypertension	6.52e-06	0.000122	CcSEcCtD
Guanabenz—Oedema—Timolol—hypertension	6.51e-06	0.000121	CcSEcCtD
Guanabenz—Loss of consciousness—Lisinopril—hypertension	6.5e-06	0.000121	CcSEcCtD
Guanabenz—Rash—Verapamil—hypertension	6.5e-06	0.000121	CcSEcCtD
Guanabenz—Urticaria—Hydrochlorothiazide—hypertension	6.5e-06	0.000121	CcSEcCtD
Guanabenz—Tachycardia—Ramipril—hypertension	6.5e-06	0.000121	CcSEcCtD
Guanabenz—Dermatitis—Verapamil—hypertension	6.5e-06	0.000121	CcSEcCtD
Guanabenz—Headache—Nifedipine—hypertension	6.49e-06	0.000121	CcSEcCtD
Guanabenz—Pruritus—Clonidine—hypertension	6.48e-06	0.000121	CcSEcCtD
Guanabenz—Body temperature increased—Hydrochlorothiazide—hypertension	6.47e-06	0.000121	CcSEcCtD
Guanabenz—Abdominal pain—Hydrochlorothiazide—hypertension	6.47e-06	0.000121	CcSEcCtD
Guanabenz—Skin disorder—Ramipril—hypertension	6.47e-06	0.000121	CcSEcCtD
Guanabenz—Infection—Timolol—hypertension	6.47e-06	0.000121	CcSEcCtD
Guanabenz—Headache—Verapamil—hypertension	6.46e-06	0.000121	CcSEcCtD
Guanabenz—Hypersensitivity—Telmisartan—hypertension	6.46e-06	0.000121	CcSEcCtD
Guanabenz—Cough—Lisinopril—hypertension	6.46e-06	0.000121	CcSEcCtD
Guanabenz—Nausea—Indapamide—hypertension	6.45e-06	0.00012	CcSEcCtD
Guanabenz—Nausea—Diltiazem—hypertension	6.45e-06	0.00012	CcSEcCtD
Guanabenz—Asthenia—Trandolapril—hypertension	6.41e-06	0.00012	CcSEcCtD
Guanabenz—Shock—Timolol—hypertension	6.41e-06	0.00012	CcSEcCtD
Guanabenz—Feeling abnormal—Losartan—hypertension	6.4e-06	0.000119	CcSEcCtD
Guanabenz—Urticaria—Furosemide—hypertension	6.39e-06	0.000119	CcSEcCtD
Guanabenz—Nervous system disorder—Timolol—hypertension	6.38e-06	0.000119	CcSEcCtD
Guanabenz—Nausea—Carvedilol—hypertension	6.38e-06	0.000119	CcSEcCtD
Guanabenz—Asthenia—Enalapril—hypertension	6.38e-06	0.000119	CcSEcCtD
Guanabenz—Abdominal pain—Furosemide—hypertension	6.36e-06	0.000119	CcSEcCtD
Guanabenz—Body temperature increased—Furosemide—hypertension	6.36e-06	0.000119	CcSEcCtD
Guanabenz—Gastrointestinal pain—Losartan—hypertension	6.35e-06	0.000119	CcSEcCtD
Guanabenz—Dizziness—Valsartan—hypertension	6.35e-06	0.000119	CcSEcCtD
Guanabenz—Anorexia—Ramipril—hypertension	6.35e-06	0.000118	CcSEcCtD
Guanabenz—Urticaria—Betaxolol—hypertension	6.33e-06	0.000118	CcSEcCtD
Guanabenz—Skin disorder—Timolol—hypertension	6.32e-06	0.000118	CcSEcCtD
Guanabenz—Dizziness—Olmesartan—hypertension	6.32e-06	0.000118	CcSEcCtD
Guanabenz—Pruritus—Trandolapril—hypertension	6.32e-06	0.000118	CcSEcCtD
Guanabenz—Nausea—Doxazosin—hypertension	6.31e-06	0.000118	CcSEcCtD
Guanabenz—Chest pain—Lisinopril—hypertension	6.3e-06	0.000118	CcSEcCtD
Guanabenz—Myalgia—Lisinopril—hypertension	6.3e-06	0.000118	CcSEcCtD
Guanabenz—Arthralgia—Lisinopril—hypertension	6.3e-06	0.000118	CcSEcCtD
Guanabenz—Body temperature increased—Betaxolol—hypertension	6.3e-06	0.000118	CcSEcCtD
Guanabenz—Asthenia—Telmisartan—hypertension	6.29e-06	0.000117	CcSEcCtD
Guanabenz—Pruritus—Enalapril—hypertension	6.29e-06	0.000117	CcSEcCtD
Guanabenz—Anxiety—Lisinopril—hypertension	6.28e-06	0.000117	CcSEcCtD
Guanabenz—Diarrhoea—Clonidine—hypertension	6.26e-06	0.000117	CcSEcCtD
Guanabenz—Nausea—Fosinopril—hypertension	6.24e-06	0.000116	CcSEcCtD
Guanabenz—Discomfort—Lisinopril—hypertension	6.22e-06	0.000116	CcSEcCtD
Guanabenz—Hypotension—Ramipril—hypertension	6.22e-06	0.000116	CcSEcCtD
Guanabenz—Anorexia—Timolol—hypertension	6.21e-06	0.000116	CcSEcCtD
Guanabenz—Pruritus—Telmisartan—hypertension	6.21e-06	0.000116	CcSEcCtD
Guanabenz—Nausea—Eplerenone—hypertension	6.2e-06	0.000116	CcSEcCtD
Guanabenz—Urticaria—Losartan—hypertension	6.17e-06	0.000115	CcSEcCtD
Guanabenz—Dry mouth—Lisinopril—hypertension	6.16e-06	0.000115	CcSEcCtD
Guanabenz—Nausea—Nifedipine—hypertension	6.15e-06	0.000115	CcSEcCtD
Guanabenz—Abdominal pain—Losartan—hypertension	6.14e-06	0.000115	CcSEcCtD
Guanabenz—Body temperature increased—Losartan—hypertension	6.14e-06	0.000115	CcSEcCtD
Guanabenz—Nausea—Verapamil—hypertension	6.13e-06	0.000114	CcSEcCtD
Guanabenz—Asthenia—Captopril—hypertension	6.12e-06	0.000114	CcSEcCtD
Guanabenz—Diarrhoea—Trandolapril—hypertension	6.11e-06	0.000114	CcSEcCtD
Guanabenz—Vomiting—Valsartan—hypertension	6.11e-06	0.000114	CcSEcCtD
Guanabenz—Confusional state—Lisinopril—hypertension	6.09e-06	0.000114	CcSEcCtD
Guanabenz—Diarrhoea—Enalapril—hypertension	6.08e-06	0.000114	CcSEcCtD
Guanabenz—Hypotension—Timolol—hypertension	6.08e-06	0.000114	CcSEcCtD
Guanabenz—Hypersensitivity—Irbesartan—hypertension	6.08e-06	0.000113	CcSEcCtD
Guanabenz—Vomiting—Olmesartan—hypertension	6.08e-06	0.000113	CcSEcCtD
Guanabenz—Musculoskeletal discomfort—Ramipril—hypertension	6.07e-06	0.000113	CcSEcCtD
Guanabenz—Rash—Valsartan—hypertension	6.06e-06	0.000113	CcSEcCtD
Guanabenz—Dizziness—Clonidine—hypertension	6.05e-06	0.000113	CcSEcCtD
Guanabenz—Dermatitis—Valsartan—hypertension	6.05e-06	0.000113	CcSEcCtD
Guanabenz—Oedema—Lisinopril—hypertension	6.04e-06	0.000113	CcSEcCtD
Guanabenz—Pruritus—Captopril—hypertension	6.03e-06	0.000113	CcSEcCtD
Guanabenz—Hypersensitivity—Hydrochlorothiazide—hypertension	6.03e-06	0.000113	CcSEcCtD
Guanabenz—Rash—Olmesartan—hypertension	6.03e-06	0.000112	CcSEcCtD
Guanabenz—Dermatitis—Olmesartan—hypertension	6.02e-06	0.000112	CcSEcCtD
Guanabenz—Headache—Valsartan—hypertension	6.02e-06	0.000112	CcSEcCtD
Guanabenz—Diarrhoea—Telmisartan—hypertension	6e-06	0.000112	CcSEcCtD
Guanabenz—Infection—Lisinopril—hypertension	6e-06	0.000112	CcSEcCtD
Guanabenz—Headache—Olmesartan—hypertension	5.99e-06	0.000112	CcSEcCtD
Guanabenz—Paraesthesia—Ramipril—hypertension	5.98e-06	0.000112	CcSEcCtD
Guanabenz—Shock—Lisinopril—hypertension	5.94e-06	0.000111	CcSEcCtD
Guanabenz—Asthenia—Perindopril—hypertension	5.94e-06	0.000111	CcSEcCtD
Guanabenz—Dyspnoea—Ramipril—hypertension	5.94e-06	0.000111	CcSEcCtD
Guanabenz—Musculoskeletal discomfort—Timolol—hypertension	5.93e-06	0.000111	CcSEcCtD
Guanabenz—Hypersensitivity—Furosemide—hypertension	5.93e-06	0.000111	CcSEcCtD
Guanabenz—Asthenia—Irbesartan—hypertension	5.92e-06	0.00011	CcSEcCtD
Guanabenz—Thrombocytopenia—Lisinopril—hypertension	5.91e-06	0.00011	CcSEcCtD
Guanabenz—Dizziness—Trandolapril—hypertension	5.9e-06	0.00011	CcSEcCtD
Guanabenz—Tachycardia—Lisinopril—hypertension	5.89e-06	0.00011	CcSEcCtD
Guanabenz—Dizziness—Enalapril—hypertension	5.88e-06	0.00011	CcSEcCtD
Guanabenz—Asthenia—Hydrochlorothiazide—hypertension	5.87e-06	0.00011	CcSEcCtD
Guanabenz—Hypersensitivity—Betaxolol—hypertension	5.87e-06	0.00011	CcSEcCtD
Guanabenz—Skin disorder—Lisinopril—hypertension	5.87e-06	0.000109	CcSEcCtD
Guanabenz—Dyspepsia—Ramipril—hypertension	5.86e-06	0.000109	CcSEcCtD
Guanabenz—Pruritus—Perindopril—hypertension	5.86e-06	0.000109	CcSEcCtD
Guanabenz—Paraesthesia—Timolol—hypertension	5.85e-06	0.000109	CcSEcCtD
Guanabenz—Pruritus—Irbesartan—hypertension	5.84e-06	0.000109	CcSEcCtD
Guanabenz—Diarrhoea—Captopril—hypertension	5.84e-06	0.000109	CcSEcCtD
Guanabenz—Vomiting—Clonidine—hypertension	5.82e-06	0.000109	CcSEcCtD
Guanabenz—Dyspnoea—Timolol—hypertension	5.8e-06	0.000108	CcSEcCtD
Guanabenz—Dizziness—Telmisartan—hypertension	5.8e-06	0.000108	CcSEcCtD
Guanabenz—Pruritus—Hydrochlorothiazide—hypertension	5.79e-06	0.000108	CcSEcCtD
Guanabenz—Decreased appetite—Ramipril—hypertension	5.79e-06	0.000108	CcSEcCtD
Guanabenz—Asthenia—Furosemide—hypertension	5.78e-06	0.000108	CcSEcCtD
Guanabenz—Rash—Clonidine—hypertension	5.77e-06	0.000108	CcSEcCtD
Guanabenz—Dermatitis—Clonidine—hypertension	5.77e-06	0.000108	CcSEcCtD
Guanabenz—Anorexia—Lisinopril—hypertension	5.76e-06	0.000107	CcSEcCtD
Guanabenz—Gastrointestinal disorder—Ramipril—hypertension	5.75e-06	0.000107	CcSEcCtD
Guanabenz—Fatigue—Ramipril—hypertension	5.74e-06	0.000107	CcSEcCtD
Guanabenz—Headache—Clonidine—hypertension	5.73e-06	0.000107	CcSEcCtD
Guanabenz—Dyspepsia—Timolol—hypertension	5.73e-06	0.000107	CcSEcCtD
Guanabenz—Hypersensitivity—Losartan—hypertension	5.72e-06	0.000107	CcSEcCtD
Guanabenz—Asthenia—Betaxolol—hypertension	5.72e-06	0.000107	CcSEcCtD
Guanabenz—Nausea—Valsartan—hypertension	5.7e-06	0.000106	CcSEcCtD
Guanabenz—Pruritus—Furosemide—hypertension	5.7e-06	0.000106	CcSEcCtD
Guanabenz—Constipation—Ramipril—hypertension	5.7e-06	0.000106	CcSEcCtD
Guanabenz—Nausea—Olmesartan—hypertension	5.68e-06	0.000106	CcSEcCtD
Guanabenz—Vomiting—Trandolapril—hypertension	5.68e-06	0.000106	CcSEcCtD
Guanabenz—Diarrhoea—Perindopril—hypertension	5.67e-06	0.000106	CcSEcCtD
Guanabenz—Decreased appetite—Timolol—hypertension	5.66e-06	0.000106	CcSEcCtD
Guanabenz—Vomiting—Enalapril—hypertension	5.65e-06	0.000106	CcSEcCtD
Guanabenz—Diarrhoea—Irbesartan—hypertension	5.65e-06	0.000105	CcSEcCtD
Guanabenz—Hypotension—Lisinopril—hypertension	5.64e-06	0.000105	CcSEcCtD
Guanabenz—Dizziness—Captopril—hypertension	5.64e-06	0.000105	CcSEcCtD
Guanabenz—Pruritus—Betaxolol—hypertension	5.64e-06	0.000105	CcSEcCtD
Guanabenz—Rash—Trandolapril—hypertension	5.63e-06	0.000105	CcSEcCtD
Guanabenz—Dermatitis—Trandolapril—hypertension	5.62e-06	0.000105	CcSEcCtD
Guanabenz—Gastrointestinal disorder—Timolol—hypertension	5.62e-06	0.000105	CcSEcCtD
Guanabenz—Fatigue—Timolol—hypertension	5.61e-06	0.000105	CcSEcCtD
Guanabenz—Rash—Enalapril—hypertension	5.61e-06	0.000105	CcSEcCtD
Guanabenz—Dermatitis—Enalapril—hypertension	5.6e-06	0.000105	CcSEcCtD
Guanabenz—Diarrhoea—Hydrochlorothiazide—hypertension	5.6e-06	0.000105	CcSEcCtD
Guanabenz—Headache—Trandolapril—hypertension	5.59e-06	0.000104	CcSEcCtD
Guanabenz—Vomiting—Telmisartan—hypertension	5.58e-06	0.000104	CcSEcCtD
Guanabenz—Asthenia—Losartan—hypertension	5.57e-06	0.000104	CcSEcCtD
Guanabenz—Headache—Enalapril—hypertension	5.57e-06	0.000104	CcSEcCtD
Guanabenz—Pain—Timolol—hypertension	5.57e-06	0.000104	CcSEcCtD
Guanabenz—Rash—Telmisartan—hypertension	5.53e-06	0.000103	CcSEcCtD
Guanabenz—Dermatitis—Telmisartan—hypertension	5.52e-06	0.000103	CcSEcCtD
Guanabenz—Diarrhoea—Furosemide—hypertension	5.51e-06	0.000103	CcSEcCtD
Guanabenz—Musculoskeletal discomfort—Lisinopril—hypertension	5.5e-06	0.000103	CcSEcCtD
Guanabenz—Pruritus—Losartan—hypertension	5.49e-06	0.000103	CcSEcCtD
Guanabenz—Headache—Telmisartan—hypertension	5.49e-06	0.000103	CcSEcCtD
Guanabenz—Feeling abnormal—Ramipril—hypertension	5.49e-06	0.000102	CcSEcCtD
Guanabenz—Dizziness—Perindopril—hypertension	5.48e-06	0.000102	CcSEcCtD
Guanabenz—Dizziness—Irbesartan—hypertension	5.46e-06	0.000102	CcSEcCtD
Guanabenz—Diarrhoea—Betaxolol—hypertension	5.45e-06	0.000102	CcSEcCtD
Guanabenz—Gastrointestinal pain—Ramipril—hypertension	5.45e-06	0.000102	CcSEcCtD
Guanabenz—Nausea—Clonidine—hypertension	5.44e-06	0.000101	CcSEcCtD
Guanabenz—Paraesthesia—Lisinopril—hypertension	5.42e-06	0.000101	CcSEcCtD
Guanabenz—Vomiting—Captopril—hypertension	5.42e-06	0.000101	CcSEcCtD
Guanabenz—Dizziness—Hydrochlorothiazide—hypertension	5.41e-06	0.000101	CcSEcCtD
Guanabenz—Dyspnoea—Lisinopril—hypertension	5.38e-06	0.0001	CcSEcCtD
Guanabenz—Rash—Captopril—hypertension	5.38e-06	0.0001	CcSEcCtD
Guanabenz—Dermatitis—Captopril—hypertension	5.37e-06	0.0001	CcSEcCtD
Guanabenz—Feeling abnormal—Timolol—hypertension	5.37e-06	0.0001	CcSEcCtD
Guanabenz—Headache—Captopril—hypertension	5.34e-06	9.97e-05	CcSEcCtD
Guanabenz—Gastrointestinal pain—Timolol—hypertension	5.32e-06	9.93e-05	CcSEcCtD
Guanabenz—Dizziness—Furosemide—hypertension	5.32e-06	9.93e-05	CcSEcCtD
Guanabenz—Dyspepsia—Lisinopril—hypertension	5.32e-06	9.92e-05	CcSEcCtD
Guanabenz—Diarrhoea—Losartan—hypertension	5.31e-06	9.92e-05	CcSEcCtD
Guanabenz—Nausea—Trandolapril—hypertension	5.3e-06	9.9e-05	CcSEcCtD
Guanabenz—Urticaria—Ramipril—hypertension	5.29e-06	9.87e-05	CcSEcCtD
Guanabenz—Nausea—Enalapril—hypertension	5.28e-06	9.86e-05	CcSEcCtD
Guanabenz—Dizziness—Betaxolol—hypertension	5.27e-06	9.83e-05	CcSEcCtD
Guanabenz—Vomiting—Perindopril—hypertension	5.26e-06	9.82e-05	CcSEcCtD
Guanabenz—Abdominal pain—Ramipril—hypertension	5.26e-06	9.82e-05	CcSEcCtD
Guanabenz—Body temperature increased—Ramipril—hypertension	5.26e-06	9.82e-05	CcSEcCtD
Guanabenz—Decreased appetite—Lisinopril—hypertension	5.25e-06	9.8e-05	CcSEcCtD
Guanabenz—Vomiting—Irbesartan—hypertension	5.25e-06	9.79e-05	CcSEcCtD
Guanabenz—Rash—Perindopril—hypertension	5.22e-06	9.74e-05	CcSEcCtD
Guanabenz—Dermatitis—Perindopril—hypertension	5.22e-06	9.73e-05	CcSEcCtD
Guanabenz—Gastrointestinal disorder—Lisinopril—hypertension	5.21e-06	9.73e-05	CcSEcCtD
Guanabenz—Nausea—Telmisartan—hypertension	5.21e-06	9.72e-05	CcSEcCtD
Guanabenz—Fatigue—Lisinopril—hypertension	5.21e-06	9.72e-05	CcSEcCtD
Guanabenz—Vomiting—Hydrochlorothiazide—hypertension	5.2e-06	9.71e-05	CcSEcCtD
Guanabenz—Rash—Irbesartan—hypertension	5.2e-06	9.71e-05	CcSEcCtD
Guanabenz—Dermatitis—Irbesartan—hypertension	5.2e-06	9.7e-05	CcSEcCtD
Guanabenz—Headache—Perindopril—hypertension	5.19e-06	9.68e-05	CcSEcCtD
Guanabenz—Urticaria—Timolol—hypertension	5.17e-06	9.65e-05	CcSEcCtD
Guanabenz—Headache—Irbesartan—hypertension	5.17e-06	9.65e-05	CcSEcCtD
Guanabenz—Constipation—Lisinopril—hypertension	5.16e-06	9.64e-05	CcSEcCtD
Guanabenz—Pain—Lisinopril—hypertension	5.16e-06	9.64e-05	CcSEcCtD
Guanabenz—Rash—Hydrochlorothiazide—hypertension	5.16e-06	9.63e-05	CcSEcCtD
Guanabenz—Dermatitis—Hydrochlorothiazide—hypertension	5.16e-06	9.62e-05	CcSEcCtD
Guanabenz—Abdominal pain—Timolol—hypertension	5.15e-06	9.6e-05	CcSEcCtD
Guanabenz—Body temperature increased—Timolol—hypertension	5.15e-06	9.6e-05	CcSEcCtD
Guanabenz—Dizziness—Losartan—hypertension	5.14e-06	9.58e-05	CcSEcCtD
Guanabenz—Headache—Hydrochlorothiazide—hypertension	5.13e-06	9.57e-05	CcSEcCtD
Guanabenz—Vomiting—Furosemide—hypertension	5.12e-06	9.55e-05	CcSEcCtD
Guanabenz—Rash—Furosemide—hypertension	5.08e-06	9.47e-05	CcSEcCtD
Guanabenz—Dermatitis—Furosemide—hypertension	5.07e-06	9.46e-05	CcSEcCtD
Guanabenz—Vomiting—Betaxolol—hypertension	5.07e-06	9.46e-05	CcSEcCtD
Guanabenz—Nausea—Captopril—hypertension	5.07e-06	9.45e-05	CcSEcCtD
Guanabenz—Headache—Furosemide—hypertension	5.04e-06	9.41e-05	CcSEcCtD
Guanabenz—Rash—Betaxolol—hypertension	5.02e-06	9.38e-05	CcSEcCtD
Guanabenz—Dermatitis—Betaxolol—hypertension	5.02e-06	9.37e-05	CcSEcCtD
Guanabenz—Headache—Betaxolol—hypertension	4.99e-06	9.32e-05	CcSEcCtD
Guanabenz—Feeling abnormal—Lisinopril—hypertension	4.98e-06	9.29e-05	CcSEcCtD
Guanabenz—Gastrointestinal pain—Lisinopril—hypertension	4.94e-06	9.22e-05	CcSEcCtD
Guanabenz—Vomiting—Losartan—hypertension	4.94e-06	9.22e-05	CcSEcCtD
Guanabenz—Nausea—Perindopril—hypertension	4.92e-06	9.18e-05	CcSEcCtD
Guanabenz—Hypersensitivity—Ramipril—hypertension	4.91e-06	9.16e-05	CcSEcCtD
Guanabenz—Nausea—Irbesartan—hypertension	4.9e-06	9.15e-05	CcSEcCtD
Guanabenz—Rash—Losartan—hypertension	4.9e-06	9.14e-05	CcSEcCtD
Guanabenz—Dermatitis—Losartan—hypertension	4.89e-06	9.13e-05	CcSEcCtD
Guanabenz—Headache—Losartan—hypertension	4.87e-06	9.08e-05	CcSEcCtD
Guanabenz—Nausea—Hydrochlorothiazide—hypertension	4.86e-06	9.07e-05	CcSEcCtD
Guanabenz—Urticaria—Lisinopril—hypertension	4.8e-06	8.95e-05	CcSEcCtD
Guanabenz—Hypersensitivity—Timolol—hypertension	4.8e-06	8.95e-05	CcSEcCtD
Guanabenz—Nausea—Furosemide—hypertension	4.78e-06	8.92e-05	CcSEcCtD
Guanabenz—Asthenia—Ramipril—hypertension	4.78e-06	8.92e-05	CcSEcCtD
Guanabenz—Abdominal pain—Lisinopril—hypertension	4.77e-06	8.91e-05	CcSEcCtD
Guanabenz—Body temperature increased—Lisinopril—hypertension	4.77e-06	8.91e-05	CcSEcCtD
Guanabenz—Nausea—Betaxolol—hypertension	4.73e-06	8.83e-05	CcSEcCtD
Guanabenz—Pruritus—Ramipril—hypertension	4.71e-06	8.79e-05	CcSEcCtD
Guanabenz—Asthenia—Timolol—hypertension	4.67e-06	8.72e-05	CcSEcCtD
Guanabenz—Nausea—Losartan—hypertension	4.61e-06	8.61e-05	CcSEcCtD
Guanabenz—Pruritus—Timolol—hypertension	4.61e-06	8.6e-05	CcSEcCtD
Guanabenz—Diarrhoea—Ramipril—hypertension	4.56e-06	8.5e-05	CcSEcCtD
Guanabenz—Diarrhoea—Timolol—hypertension	4.45e-06	8.31e-05	CcSEcCtD
Guanabenz—Hypersensitivity—Lisinopril—hypertension	4.45e-06	8.3e-05	CcSEcCtD
Guanabenz—Dizziness—Ramipril—hypertension	4.4e-06	8.22e-05	CcSEcCtD
Guanabenz—Asthenia—Lisinopril—hypertension	4.33e-06	8.09e-05	CcSEcCtD
Guanabenz—Dizziness—Timolol—hypertension	4.31e-06	8.03e-05	CcSEcCtD
Guanabenz—Pruritus—Lisinopril—hypertension	4.27e-06	7.97e-05	CcSEcCtD
Guanabenz—Vomiting—Ramipril—hypertension	4.23e-06	7.9e-05	CcSEcCtD
Guanabenz—Rash—Ramipril—hypertension	4.2e-06	7.84e-05	CcSEcCtD
Guanabenz—Dermatitis—Ramipril—hypertension	4.2e-06	7.83e-05	CcSEcCtD
Guanabenz—Headache—Ramipril—hypertension	4.17e-06	7.79e-05	CcSEcCtD
Guanabenz—Vomiting—Timolol—hypertension	4.14e-06	7.72e-05	CcSEcCtD
Guanabenz—Diarrhoea—Lisinopril—hypertension	4.13e-06	7.71e-05	CcSEcCtD
Guanabenz—Rash—Timolol—hypertension	4.11e-06	7.66e-05	CcSEcCtD
Guanabenz—Dermatitis—Timolol—hypertension	4.1e-06	7.65e-05	CcSEcCtD
Guanabenz—Headache—Timolol—hypertension	4.08e-06	7.61e-05	CcSEcCtD
Guanabenz—Dizziness—Lisinopril—hypertension	3.99e-06	7.45e-05	CcSEcCtD
Guanabenz—Nausea—Ramipril—hypertension	3.96e-06	7.38e-05	CcSEcCtD
Guanabenz—Nausea—Timolol—hypertension	3.87e-06	7.22e-05	CcSEcCtD
Guanabenz—Vomiting—Lisinopril—hypertension	3.84e-06	7.17e-05	CcSEcCtD
Guanabenz—Rash—Lisinopril—hypertension	3.81e-06	7.11e-05	CcSEcCtD
Guanabenz—Dermatitis—Lisinopril—hypertension	3.8e-06	7.1e-05	CcSEcCtD
Guanabenz—Headache—Lisinopril—hypertension	3.78e-06	7.06e-05	CcSEcCtD
Guanabenz—Nausea—Lisinopril—hypertension	3.59e-06	6.69e-05	CcSEcCtD
Guanabenz—ADRA2B—Signaling Pathways—AGT—hypertension	1.04e-06	4.24e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—VAV3—hypertension	1.03e-06	4.23e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—PDGFA—hypertension	1.03e-06	4.23e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Hemostasis—AKT1—hypertension	1.03e-06	4.22e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—ALDH2—hypertension	1.02e-06	4.17e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—HTR2A—hypertension	1.02e-06	4.17e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—CALM1—hypertension	1.02e-06	4.17e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—TGFBR2—hypertension	1.02e-06	4.17e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—C3—hypertension	1.02e-06	4.17e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—LEP—hypertension	1.01e-06	4.15e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—APOE—hypertension	1.01e-06	4.15e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—GNB3—hypertension	1.01e-06	4.13e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—CAV1—hypertension	1.01e-06	4.12e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—APOA1—hypertension	1e-06	4.11e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—AVP—hypertension	9.95e-07	4.07e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—KDR—hypertension	9.94e-07	4.07e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—hypertension	9.94e-07	4.07e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—HBA1—hypertension	9.94e-07	4.07e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—PDGFB—hypertension	9.91e-07	4.06e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—MTHFR—hypertension	9.89e-07	4.05e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—CYP11A1—hypertension	9.88e-07	4.04e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—PPARG—hypertension	9.88e-07	4.04e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—RHOA—hypertension	9.87e-07	4.04e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—FGFR1—hypertension	9.86e-07	4.04e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—GNAS—hypertension	9.82e-07	4.02e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—POMC—hypertension	9.81e-07	4.01e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—PIK3R1—hypertension	9.77e-07	4e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—POMC—hypertension	9.74e-07	3.99e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—HIF1A—hypertension	9.71e-07	3.97e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—PPARA—hypertension	9.7e-07	3.97e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—SLC9A1—hypertension	9.7e-07	3.97e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—GSTT1—hypertension	9.7e-07	3.97e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—INS—hypertension	9.69e-07	3.96e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—AGT—hypertension	9.68e-07	3.96e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Hemostasis—AKT1—hypertension	9.63e-07	3.94e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—APOB—hypertension	9.62e-07	3.94e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—GCLC—hypertension	9.59e-07	3.92e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—CETP—hypertension	9.59e-07	3.92e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—PTK2—hypertension	9.58e-07	3.92e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—FN1—hypertension	9.57e-07	3.92e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—PRKCB—hypertension	9.57e-07	3.92e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—F2—hypertension	9.57e-07	3.92e-05	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—CXCL8—hypertension	9.54e-07	3.9e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—CALM1—hypertension	9.51e-07	3.89e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—LEP—hypertension	9.48e-07	3.88e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—APOE—hypertension	9.48e-07	3.88e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—EDN1—hypertension	9.47e-07	3.88e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—AGT—hypertension	9.4e-07	3.85e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—CCL5—hypertension	9.4e-07	3.85e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—CAV1—hypertension	9.39e-07	3.84e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—APOA1—hypertension	9.37e-07	3.84e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—NOTCH1—hypertension	9.37e-07	3.83e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—KDR—hypertension	9.29e-07	3.8e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Hemostasis—TP53—hypertension	9.26e-07	3.79e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—CALM1—hypertension	9.24e-07	3.78e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—APOE—hypertension	9.21e-07	3.77e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—LPL—hypertension	9.19e-07	3.76e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—CYP17A1—hypertension	9.18e-07	3.76e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—CAV1—hypertension	9.12e-07	3.73e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—H2AFX—hypertension	9.12e-07	3.73e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—RPS6KB1—hypertension	9.1e-07	3.73e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—PDGFRB—hypertension	9.1e-07	3.73e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—APOA1—hypertension	9.1e-07	3.73e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—ENO1—hypertension	9.09e-07	3.72e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—PTGS1—hypertension	9.09e-07	3.72e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—ADCY5—hypertension	8.99e-07	3.68e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—F2—hypertension	8.94e-07	3.66e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—FN1—hypertension	8.94e-07	3.66e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—PRKCB—hypertension	8.94e-07	3.66e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hypertension	8.94e-07	3.66e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—PRKCG—hypertension	8.93e-07	3.66e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—ALB—hypertension	8.88e-07	3.63e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—ITGB3—hypertension	8.87e-07	3.63e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—PRKCA—hypertension	8.87e-07	3.63e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—YWHAZ—hypertension	8.8e-07	3.6e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—CTGF—hypertension	8.75e-07	3.58e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—NOTCH1—hypertension	8.75e-07	3.58e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—POMC—hypertension	8.72e-07	3.57e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—NGF—hypertension	8.7e-07	3.56e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—SPP1—hypertension	8.7e-07	3.56e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—HMGCR—hypertension	8.67e-07	3.55e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—GOT2—hypertension	8.67e-07	3.55e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—INS—hypertension	8.67e-07	3.55e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—CXCL8—hypertension	8.66e-07	3.55e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hypertension	8.55e-07	3.5e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—CCL2—hypertension	8.53e-07	3.49e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—NOS3—hypertension	8.49e-07	3.48e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—PIK3R1—hypertension	8.49e-07	3.48e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—ADRA2A—hypertension	8.49e-07	3.47e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—PRKCD—hypertension	8.46e-07	3.46e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—CCR5—hypertension	8.46e-07	3.46e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—IGF1—hypertension	8.39e-07	3.43e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—AKT2—hypertension	8.38e-07	3.43e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—EGFR—hypertension	8.34e-07	3.42e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—HTR2A—hypertension	8.28e-07	3.39e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—C3—hypertension	8.27e-07	3.39e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—POMC—hypertension	8.14e-07	3.33e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—INS—hypertension	8.1e-07	3.31e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—PDGFB—hypertension	8.05e-07	3.29e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—PPARG—hypertension	8.02e-07	3.28e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—FGFR1—hypertension	8.01e-07	3.28e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—CCL2—hypertension	7.97e-07	3.26e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—SERPINE1—hypertension	7.96e-07	3.26e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—TH—hypertension	7.95e-07	3.25e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—CALM2—hypertension	7.92e-07	3.24e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—POMC—hypertension	7.91e-07	3.24e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—HIF1A—hypertension	7.89e-07	3.23e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—INS—hypertension	7.87e-07	3.22e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—AGT—hypertension	7.86e-07	3.22e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—IGF1—hypertension	7.83e-07	3.21e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—AKT2—hypertension	7.83e-07	3.2e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Hemostasis—AKT1—hypertension	7.82e-07	3.2e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—hypertension	7.82e-07	3.2e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—EGFR—hypertension	7.8e-07	3.19e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—PTGS2—hypertension	7.77e-07	3.18e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—SLC2A4—hypertension	7.73e-07	3.16e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—GCG—hypertension	7.73e-07	3.16e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—CALM1—hypertension	7.73e-07	3.16e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—FGF2—hypertension	7.71e-07	3.16e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—APOE—hypertension	7.7e-07	3.15e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—LEP—hypertension	7.7e-07	3.15e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—RHOA—hypertension	7.68e-07	3.14e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—CAV1—hypertension	7.63e-07	3.12e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—APOA1—hypertension	7.61e-07	3.12e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—PIK3R1—hypertension	7.6e-07	3.11e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—NOS3—hypertension	7.6e-07	3.11e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—KDR—hypertension	7.54e-07	3.09e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—GOT1—hypertension	7.49e-07	3.06e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—SERPINE1—hypertension	7.44e-07	3.04e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—CYP19A1—hypertension	7.27e-07	2.97e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—STK11—hypertension	7.27e-07	2.97e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—PRKCB—hypertension	7.26e-07	2.97e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—F2—hypertension	7.26e-07	2.97e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—FN1—hypertension	7.26e-07	2.97e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—ALB—hypertension	7.21e-07	2.95e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—FGF2—hypertension	7.2e-07	2.95e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—RHOA—hypertension	7.18e-07	2.94e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—RELA—hypertension	7.16e-07	2.93e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—NOTCH1—hypertension	7.11e-07	2.91e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—PIK3R1—hypertension	7.1e-07	2.91e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—NOS3—hypertension	7.1e-07	2.91e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—MTOR—hypertension	7.02e-07	2.87e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—NOS3—hypertension	6.9e-07	2.82e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—PIK3R1—hypertension	6.9e-07	2.82e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hypertension	6.82e-07	2.79e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—PTEN—hypertension	6.78e-07	2.77e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—COMT—hypertension	6.76e-07	2.76e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—CXCL8—hypertension	6.74e-07	2.76e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—RELA—hypertension	6.69e-07	2.74e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—PPARGC1A—hypertension	6.66e-07	2.73e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—GNB3—hypertension	6.66e-07	2.73e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—HMOX1—hypertension	6.63e-07	2.71e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—POMC—hypertension	6.62e-07	2.71e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—INS—hypertension	6.58e-07	2.69e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—MTOR—hypertension	6.56e-07	2.68e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—CAT—hypertension	6.54e-07	2.68e-05	CbGpPWpGaD
Guanabenz—ADRA2B—GPCR downstream signaling—AKT1—hypertension	6.52e-07	2.67e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hypertension	6.51e-07	2.66e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—GNAS—hypertension	6.49e-07	2.65e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—CCL2—hypertension	6.47e-07	2.65e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—EP300—hypertension	6.46e-07	2.64e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—IL6—hypertension	6.41e-07	2.62e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—IGF1—hypertension	6.36e-07	2.6e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—AKT2—hypertension	6.36e-07	2.6e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—APOB—hypertension	6.35e-07	2.6e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—EGFR—hypertension	6.33e-07	2.59e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—PTGS2—hypertension	6.31e-07	2.58e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—CXCL8—hypertension	6.3e-07	2.58e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—GSTM1—hypertension	6.18e-07	2.53e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—MMP9—hypertension	6.1e-07	2.5e-05	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR downstream signaling—AKT1—hypertension	6.09e-07	2.49e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—CDKN1A—hypertension	6.08e-07	2.49e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—LPL—hypertension	6.06e-07	2.48e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—PTEN—hypertension	6.06e-07	2.48e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—SERPINE1—hypertension	6.04e-07	2.47e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—IL6—hypertension	5.99e-07	2.45e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—ADCY5—hypertension	5.94e-07	2.43e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—MAPK8—hypertension	5.93e-07	2.43e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—GPX1—hypertension	5.92e-07	2.42e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—AKT1—hypertension	5.92e-07	2.42e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—PRKCA—hypertension	5.86e-07	2.4e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—CYP1A1—hypertension	5.86e-07	2.4e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—FGF2—hypertension	5.85e-07	2.39e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—RHOA—hypertension	5.83e-07	2.39e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—EP300—hypertension	5.78e-07	2.37e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—NOS3—hypertension	5.77e-07	2.36e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—PIK3R1—hypertension	5.77e-07	2.36e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—CD36—hypertension	5.76e-07	2.36e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—MMP9—hypertension	5.7e-07	2.33e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—CDKN1A—hypertension	5.68e-07	2.32e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—PTEN—hypertension	5.67e-07	2.32e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—SRC—hypertension	5.62e-07	2.3e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—MAPK8—hypertension	5.54e-07	2.27e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—AKT1—hypertension	5.53e-07	2.26e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—PTEN—hypertension	5.5e-07	2.25e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—VEGFA—hypertension	5.48e-07	2.24e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—MTHFR—hypertension	5.46e-07	2.23e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—RELA—hypertension	5.43e-07	2.22e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—EP300—hypertension	5.4e-07	2.21e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—PPARA—hypertension	5.36e-07	2.19e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—MTOR—hypertension	5.33e-07	2.18e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—SRC—hypertension	5.25e-07	2.15e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—EP300—hypertension	5.25e-07	2.15e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—AGT—hypertension	5.19e-07	2.12e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—CXCL8—hypertension	5.12e-07	2.09e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—VEGFA—hypertension	5.12e-07	2.09e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—CALM1—hypertension	5.1e-07	2.09e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—APOE—hypertension	5.08e-07	2.08e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—MYC—hypertension	5.04e-07	2.06e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—CAV1—hypertension	5.04e-07	2.06e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—TGFB1—hypertension	5.03e-07	2.06e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—APOA1—hypertension	5.03e-07	2.06e-05	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—AKT1—hypertension	4.94e-07	2.02e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—EGFR—hypertension	4.93e-07	2.02e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—IL6—hypertension	4.87e-07	1.99e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—MYC—hypertension	4.71e-07	1.93e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—TGFB1—hypertension	4.7e-07	1.92e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—MMP9—hypertension	4.63e-07	1.89e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—CDKN1A—hypertension	4.61e-07	1.89e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—EGFR—hypertension	4.6e-07	1.88e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—PTEN—hypertension	4.6e-07	1.88e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—MAPK8—hypertension	4.5e-07	1.84e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—AKT1—hypertension	4.49e-07	1.84e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—PPARG—hypertension	4.43e-07	1.81e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—EP300—hypertension	4.39e-07	1.8e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—POMC—hypertension	4.37e-07	1.79e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—INS—hypertension	4.34e-07	1.78e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—SRC—hypertension	4.27e-07	1.75e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—VEGFA—hypertension	4.16e-07	1.7e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—TP53—hypertension	4.14e-07	1.69e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—ALB—hypertension	3.98e-07	1.63e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—AKT1—hypertension	3.9e-07	1.6e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—TP53—hypertension	3.87e-07	1.58e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—MYC—hypertension	3.82e-07	1.57e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—TGFB1—hypertension	3.81e-07	1.56e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—PIK3R1—hypertension	3.81e-07	1.56e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—NOS3—hypertension	3.81e-07	1.56e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—IL6—hypertension	3.79e-07	1.55e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—EGFR—hypertension	3.74e-07	1.53e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—IL6—hypertension	3.54e-07	1.45e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—AKT1—hypertension	3.5e-07	1.43e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—PTGS2—hypertension	3.48e-07	1.43e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—AKT1—hypertension	3.26e-07	1.34e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—AKT1—hypertension	3.17e-07	1.3e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—TP53—hypertension	3.14e-07	1.29e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—PTEN—hypertension	3.04e-07	1.24e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—EP300—hypertension	2.9e-07	1.19e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—IL6—hypertension	2.87e-07	1.18e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—AKT1—hypertension	2.65e-07	1.09e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—AKT1—hypertension	1.75e-07	7.17e-06	CbGpPWpGaD
